{"canonical":"https://abierto.us/vendors/rigel-pharmaceuticals-inc-x7mhpbcmhfm3","key":"X7MHPBCMHFM3","name":"RIGEL PHARMACEUTICALS INC","uei":"X7MHPBCMHFM3","city":"SOUTH SAN FRANCISCO","state":"CA","awards":2,"obligated":"0","notices_won":0,"top_agency_name":"Department of Veterans Affairs","top_naics":"325412","cage":"60TS7","parent_name":"RIGEL PHARMACEUTICALS INC","also_known_as":[],"country":"USA","actions":9,"first_action":"2024-02-13","last_action":"2026-05-21","breakdowns":{"naics":[{"key":"325412","name":null,"awards":1,"obligated":"0.00"},{"key":"541715","name":null,"awards":1,"obligated":"0.00"}],"places":[{"key":"CA","name":null,"awards":1,"obligated":"0.00"}],"agencies":[{"key":"3600","name":"Department of Veterans Affairs","awards":1,"obligated":"0.00"},{"key":"7505","name":"Office of Assistant Secretary for Preparedness and Response","awards":1,"obligated":"0.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"0.00"}],"competition":[{"key":"COMPETED UNDER SAP","name":null,"awards":1,"obligated":"0.00"},{"key":"FULL AND OPEN COMPETITION","name":null,"awards":1,"obligated":"0.00"}],"product_service_codes":[{"key":"6505","name":null,"awards":1,"obligated":"0.00"},{"key":"AN15","name":null,"awards":1,"obligated":"0.00"}]},"awards_list":[{"award_key":"CONT_AWD_75A50123C00012_7505_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75A50123C00012_7505_-NONE-_-NONE-/","piid":"75A50123C00012","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"X7MHPBCMHFM3","recipient_name":"RIGEL PHARMACEUTICALS INC","recipient_uei":"X7MHPBCMHFM3","recipient_cage":"60TS7","recipient_city":"SOUTH SAN FRANCISCO","recipient_state":"CA","sub_name":"Office of Assistant Secretary for Preparedness and Response","office_name":"BARDA - ASPR / DAAPPO / BARDA DCMA","office_key":"o-75A501","first_action_date":"2024-06-18","last_action_date":"2025-05-21","actions":4,"obligated":"0","current_total_value":"749999.00","potential_total_value":"749999.00","naics":"541715","psc":"AN15","extent_competed":"COMPETED UNDER SAP","set_aside":"NO SET ASIDE USED.","offers_received":100,"description":"RIGEL PHARMACEUTICALS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO EVALUATE THE IMPACT OF FOSTAMATINIB TREATMENT DURING HOSPITALIZATION RESULTING FROM ARDS ON LONG-TERM OUTCOMES INCLUDING CLINICAL, BIOMARKER, IMAGING, QOL, FUNCTIONAL AND LUNG FUNCTI","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null},{"award_key":"CONT_IDV_36F79724D0007_3600","permalink":"https://www.usaspending.gov/award/CONT_IDV_36F79724D0007_3600/","piid":"36F79724D0007","parent_piid":null,"award_type":null,"vendor_key":"X7MHPBCMHFM3","recipient_name":"RIGEL PHARMACEUTICALS INC","recipient_uei":"X7MHPBCMHFM3","recipient_cage":"60TS7","recipient_city":"SOUTH SAN FRANCISCO","recipient_state":"CA","sub_name":"Department of Veterans Affairs","office_name":"NAC FEDERAL SUPPLY SCHEDULE (36F797)","office_key":"o-36F797","first_action_date":"2024-02-13","last_action_date":"2026-05-21","actions":5,"obligated":"0","current_total_value":null,"potential_total_value":"19516920.00","naics":"325412","psc":"6505","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":999,"description":"DESCRIPTION CHANGE","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":2,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}